ACORA
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Nov 2023)
What this means for you
This application is over — abandoned 27 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90535685
- Mark type
- Stylized text
- Filed
- 19 Feb 2021
- Published for opposition
- 01 Mar 2022
- Abandoned
- 27 Nov 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: Proteins and biochemicals in the nature of polypeptides, peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in scientific and medical research; nutrients and nutritive products, namely, proteins and biochemicals in the nature of polypeptides, peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in the manufacture of beverages, food products and food supplements for human and non-human use; proteins for the food industry in the nature of proteins, polypeptides, peptides, and amino acids for use in the manufacture of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; biochemicals, namely, small molecules in the nature of organic compounds and metabolites for use in the manufacture of pharmaceutical preparations, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; biochemicals for in vitro and in vivo scientific research
- Class 005 — Pharmaceuticals: Dietary supplements for human and non-human use, dietary supplements for restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; nutraceuticals for treating or restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints; dietary and nutritional supplements
- Class 042 — Scientific and technological services: Research and development of medical foods, nutraceuticals, and dietary and nutritional foods and supplements for others; scientific and product research and development of proteins, polypeptides, peptides, amino acids, and small molecules for restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement
Owner
- Axcella Health Inc., Cambridge, MA, US
- Axcella Health Inc., Cambridge, MA, US
Prosecution history
- 27 Nov 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Nov 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Apr 2023 — SOU EXTENSION 2 GRANTED
- 21 Apr 2023 — SOU EXTENSION 2 FILED
- 21 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 26 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2022 — SOU EXTENSION 1 GRANTED
- 24 Oct 2022 — SOU EXTENSION 1 FILED
- 24 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 26 Apr 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Mar 2022 — PUBLISHED FOR OPPOSITION
- 09 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jan 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER